Startup Profile: Lactiga (020)

Episode 20 September 05, 2021 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 22

June 11, 2022 00:26:07
Episode Cover

Improving Emergency Dental Care: Dentriage (222)

DenTriage is a comprehensive mobile and web-based platform that will provide a convenient way for patients to receive timely guidance and care for urgent...

Listen

Episode 3

July 21, 2023 00:28:09
Episode Cover

Pathkeeper: Next Generation Surgical Robot

PathKeeper is an innovative robotic company founded in Israel.The company's disruptive, proprietary technology provides laser-like accuracy for spinal procedures. The unique technology tracks the...

Listen

Episode

June 13, 2021 00:49:54
Episode Cover

Venture Investing for Physicians (002)

In this episode, host Tobin Arthur is joined by colleague Michael Schmanske in a discussion with DJ Verret, MD, a plastic surgeon and seasoned...

Listen